Coordinated in-person evaluation
for severe allergic & type 2 inflammatory disease.
For selected patients, a coordinated in-person evaluation in Mexico City may help accelerate diagnostic clarification, advanced treatment planning, and long-term disease control — integrated with virtual second opinion and longitudinal follow-up.
Designed for patients with complex or uncontrolled disease.
This pathway is reserved for selected patients with severe asthma, CRSwNP, chronic urticaria, atopic dermatitis, eosinophilic disease or other type 2 inflammatory conditions where in-person evaluation can meaningfully change the trajectory of care.
A seven-step physician-led pathway.
- 01Advanced digital assessment
Structured intake across type 2 domains generates a clinically organized summary.
- 02Virtual specialist consultation
Phenotype-driven case review and second opinion in English or Spanish.
- 03Eligibility review
Together we determine whether an in-person evaluation is appropriate and useful.
- 04Coordinated visit to Mexico City
Practical guidance on timing, records, and logistics for a focused medical stay.
- 0548-hour diagnostic work-up
Consultations, lung function, laboratory studies and imaging coordinated efficiently.
- 06Results & personalized strategy
Phenotype/endotype discussion, treatment plan, and biologic candidacy when indicated.
- 07Longitudinal virtual follow-up
Ongoing monitoring, therapy adjustment and disease-control review from home.
Two focused days of integrated evaluation.
The 48-hour window is intended as an organizing framework, not a guarantee. Some studies may extend beyond two days depending on clinical complexity and availability.
Evaluation & studies
- ›Specialist consultations
- ›Lung function testing (spirometry, FeNO when indicated)
- ›Laboratory studies (eosinophils, IgE, type 2 biomarkers)
- ›Imaging coordination if required
- ›Additional specialty evaluations when appropriate
Integration & strategy
- ›Results review and integrated discussion
- ›Phenotype and endotype characterization
- ›Personalized treatment strategy
- ›Biologic candidacy discussion when indicated
- ›Longitudinal follow-up plan
Practical guidance for a coordinated medical visit.
Patients receive a single organized brief covering timing, documents and preparation — designed to make the medical visit efficient and unhurried.
Suggested arrival the day prior to allow for rest and intake review.
Curated hotel districts near the medical office, with transit guidance.
Prior imaging, lab results, biologic history and current prescriptions.
Specific instructions sent in advance when fasting or pauses are required.
An individualized pathway, on your terms.
Many patients prefer to attend the clinical office directly — a structured, reassuring medical environment.
When feasible, selected services can be coordinated near the patient's hotel to reduce travel during the visit.
Phenotype-driven, evidence-based strategy.
After evaluation, a personalized strategy may be developed — including biologics, immunotherapy, advanced anti-inflammatory strategies and multidisciplinary coordination when appropriate. Outcomes vary by individual.
The relationship continues after the visit.
Virtual follow-up supports treatment monitoring, disease-control review and therapy adjustment over time — integrated with your treating team at home.
Start with the digital assessment.
Eligibility for the coordinated in-person pathway is determined after your virtual specialist evaluation.